Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...

Classic cybersecurity tools are nearly powerless against semantic attacks. Signature detection, hashing, and code audits all depend on identifying explicit changes in code or data, but meaning-level ...

In this video from the American Academy of Ophthalmology meeting, Diana V. Do, MD, discusses the real-world use of aflibercept 8 mg in wet age-related macular degeneration or diabetic macular edema.

The novel extended-release formulation is expected to prevent both acute and delayed CINV for up to 5 days, improving patient compliance and convenience.

Apellis Pharmaceuticals recently announced post hoc analysis data of the GALE extension study. This new data is the result of ...

A new attack called ‘CometJacking’ exploits URL parameters to pass to Perplexity’s Comet AI browser hidden instructions that allow access to sensitive data from connected services, like email and ...

Zydus Lifesciences receives USFDA approval for generic Leuprolide Acetate injection, used in advanced prostatic cancer ...

With ultra-low latency, ASIC-driven performance, and LLM protection, Fortinet offers end-to-end security for the next ...

Drug maker Lupin on Friday said it has launched a generic medication to treat schizophrenia in the US with 180 days of ...

Cyberhaven research reveals rapid enterprise adoption of ChatGPT Atlas while highlighting critical browser agent security ...

Discover key takeaways from BKV’s Q3 2025 earnings: major Power JV stake, Texas growth, CCUS progress, and free cash flow gains.

Fed Emergency Rate Cut odds drop, but is crypto liquidity injection coming? JPMorgan expects a $300B flow. Can December FOMC ...